LIV Process Unveils Microbial Visualization Tech for Infection Control

November 06, 2025
Philadelphia-based biotech LIV Process has introduced a patented technology that makes the pathogen Clostridioides difficile visible on surfaces, allowing hospitals to detect contamination invisible to the naked eye.

LIV Process has introduced a patented microbial visualization technology at IDWeek 2025, announced in a press release. The Philadelphia-based biotech developed a system that makes the pathogen *Clostridioides difficile* visible on surfaces without the use of a microscope.

The technology uses a proprietary solution that binds to resilient spores and illuminates them under specific light wavelengths. This allows hospitals to identify contamination that is otherwise invisible to the naked eye, helping environmental services teams verify cleaning effectiveness and improve infection prevention.

*C. diff* is a leading cause of healthcare-associated infections in the United States, affecting nearly 500,000 patients annually. LIV Process is collaborating with several major health systems, including University of Virginia Health, University Health San Antonio, UMass Memorial Health, and Baptist Health, to validate and expand the use of its technology.

While the company’s current focus is on hospital environments, it plans to explore future applications in home care, long-term care, food safety, and other public settings where surface contamination poses a risk.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

11/06
Geeks360 Launches AI Platform to Integrate Marketing and Operations for Healthcare Firms
11/06
Fosun Highlights Global Innovation and AI Initiatives at Sustainability Leaders Conference
11/06
Healthcare Triangle Signs LOI to Acquire Teyame.AI for AI-Powered Patient Engagement
11/06
Bain & Company and KLAS Research Report Finds Healthcare AI Focus Shifting to ROI and Workflow Efficiency
11/06
Carta Healthcare Named to CB Insights 2025 Digital Health 50

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like